<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To study the effects of <z:chebi fb="0" ids="16119">shikimic acid</z:chebi> (SA) on focal cerebral ischemic injury after middle cerebral artery <z:mp ids='MP_0005048'>thrombosis</z:mp> (MCAT) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: <z:mp ids='MP_0005048'>Thrombosis</z:mp> was induced by <z:chebi fb="0" ids="30808">FeCl3</z:chebi> in middle cerebral artery of rats </plain></SENT>
<SENT sid="2" pm="."><plain>The influences of SA on neurologic deficit (ND), <z:mpath ids='MPATH_124'>infarct</z:mpath> size (IS), <z:hpo ids='HP_0002181'>brain edema</z:hpo>, and cerebral blood flow (CBF) in ischemic region were observed </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: SA 25 and 50 mg.kg-1 i.p. for 3 d before MCAT attenuated ND, and reduced IS by 51% and 42%; and decreased brain water content from 80.7% to 79.8% and 79.9%; and increased CBF after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> from 50.2% of the preischemic level to 75.5% and 73.3%, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>In pathologic examination, there was much less <z:mp ids='MP_0005048'>thrombosis</z:mp> in <z:chebi fb="70" ids="34342">MCA</z:chebi> in the rat with the pretreatment by SA 25 mg.kg-1 </plain></SENT>
<SENT sid="5" pm="."><plain>The extent of <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> was much less than that of control </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: SA reduced focal cerebral ischemic injury induced by middle cerebral artery <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
</text></document>